Clinical Trial Update: A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection [Phase 1]

View source ↗

Summary

This is a Phase I safety and toxicity study of the combination of Zidovudine and Didanosine in children with HIV infection. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (didanosine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED